Perrigo Positioned To Prosper From Potential Amazon OTC Product Play

CEO John Hendrickson says Perrigo would work with Amazon to develop its own private label OTC line and would not expect to lose existing customers. At a recent investor conference, he said Amazon’s commitment to the OTC category would help grow the market, not take market share from other firms.

Infrastructure

Amazon’s potential entry into the OTC drug brand arena would deal Perrigo Co. PLC a strong hand, as the firm already with 65% private label market share would be in good position to win a manufacturing deal with the e-commerce giant.

OTC drugs e-commerce still is a relatively small slice of the overall category, Perrigo CEO John Hendrickson says, estimating that online sales account for about 1%-1.5% of overall sales in the category for CVS Health Corp

Still, analysts had numerous questions about comments Hendrickson made on the potential of [Amazon.com Inc.] as a customer on Sept

More from Marketing & Advertising

More from Compliance